XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.
E
E

Ecolab


Berita

U.S. Cintas, Nasdaq, Talen Energy

U.S. RESEARCH ROUNDUP-Cintas, Nasdaq, Talen Energy Sept 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cintas, Nasdaq and Talen Energy, on Thursday. HIGHLIGHTS * Celldex Therapeutics Inc CLDX.O : Wells Fargo raises to overweight from equal weight * Cintas Corp CTAS.O : JP Morgan raises target price to $228 from $212.50 * Expedia Group Inc EXPE.O : TD Cowen cuts to hold from buy * Nasdaq Inc NDAQ.O : TD Cowen init
C
C
E
M
N
F
E
G
C
F

U.S. Avalonbay Communities, Elf Beauty, Evercore

U.S. RESEARCH ROUNDUP-Avalonbay Communities, Elf Beauty, Evercore Sept 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Avalonbay Communities, Elf Beauty and Evercore on Monday. HIGHLIGHTS * Avalonbay Communities Inc AVB.N : JP Morgan raises target price to $247 from $212 * Colgate-Palmolive Co CL.N : Wells Fargo cuts to underweight from equal-weight * Elf Beauty Inc ELF.N : Piper Sandler cuts target price to $162
C
G
G
I
C
E
E
C

U.S. Booking Holdings, Doordash, Vertex Pharmaceuticals

U.S. RESEARCH ROUNDUP- Booking Holdings, Doordash, Vertex Pharmaceuticals Aug 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Booking Holdings, Doordash and Vertex Pharmaceuticals, on Monday. HIGHLIGHTS * Academy Sports and Outdoors Inc ASO.O : JP Morgan cuts to neutral from overweight * Booking Holdings Inc BKNG.O : Jefferies cuts target price to $4350 from $4650 * Doordash DASH.O : D.A.
A
B
C
C
C
C
E
V
E
A
B
C
C
C
C

U.S. Booking Holdings, Doordash, Vertex Pharmaceuticals (Aug. 5)

CORRECTED-U.S. RESEARCH ROUNDUP-Booking Holdings, Doordash, Vertex Pharmaceuticals (Aug. 5) Corrects U.S. research roundup dated Aug. 5 to remove dated research actions from headline and tables, the errors appeared in previous versions also Aug 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Booking Holdings, Doordash and Vertex Pharmaceuticals, on Monday.
A
A
B
I
M
P
A
A
E
A
E
I
A
A
A
A
F
G
H
L
L

Ecolab misses second-quarter sales estimates, shares slump

Ecolab misses second-quarter sales estimates, shares slump July 30 (Reuters) - Ecolab ECL.N reported second-quarter sales on Tuesday that missed analysts' estimates, sending the water solutions company's shares down nearly 8%. The negative stock reaction is a combination of lower-than-expected quarterly sales and investors' more ambitious earnings growth expectations in the context of more lofty valuation metrics, Vertical Research Partners analyst Kevin McCarthy said.
E

Ecolab Q2 Adjusted EPS USD 1.68 Vs. IBES Estimate USD 1.67

BRIEF-Ecolab Q2 Adjusted EPS USD 1.68 Vs. IBES Estimate USD 1.67 Jul 30 (Reuters) - Ecolab Q2 net income USD 490.9 million. Q2 sales USD 3,985.8 million vs. IBES estimate USD 4,028 million Q2 operating income USD 656.9 million Q2 EPS USD 1.71 outlook FY adjusted EPS USD 6.5-6.7 outlook Q3 adjusted EPS USD 1.75-1.85
E

Microsoft and job openings to hit pre-Fed vigil

MORNING BID AMERICAS-Microsoft and job openings to hit pre-Fed vigil A look at the day ahead in U.S. and global markets from Mike Dolan To the extent that worries about pricey tech stocks and rising AI capex spending were partly behind last week's market shakeout, Microsoft's quarterly update should prove a key moment later on Tuesday, just as the Federal Reserve's latest policy meeting gets under way.
A
A
E
G
I
M
M
N
P
S
U
A
G
J
U
U
U
F
E
E
S
A
H
L

What to Watch in the Day Ahead - Tuesday, July 30

What to Watch in the Day Ahead - Tuesday, July 30 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT Microsoft is expected to report a rise in fourth-quarter revenue on robust demand for its AI-powered cloud and business software offerings.
M
M
M
P
Q
S
S
E
E
L

Ecolab Inc <ECL.N> expected to post earnings of $1.67 a share - Earnings Preview

Ecolab Inc expected to post earnings of $1.67 a share - Earnings Preview Ecolab Inc ECL.N , ECL is expected to show a rise in quarterly revenue when it reports results on July 30 for the period ending June 30 2024 The Saint Paul Minnesota-based company is expected to report a 4.6% increase in revenue to $4.028 billion from $3.85 billion a year ago, according to the mean estimate from 18 analysts, based on LSEG data.
E



Syarat

Aset Popular

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.